Format

Send to

Choose Destination
Klin Monbl Augenheilkd. 2018 May;235(5):576-585. doi: 10.1055/a-0573-9598. Epub 2018 May 8.

[Uveitic Secondary Glaucoma].

[Article in German; Abstract available in German from the publisher]

Author information

1
Augenabteilung am St. Franziskus-Hospital Münster.
2
Universitätsaugenklinik, Universitätsklinikum Essen.

Abstract

in English, German

An intraocular pressure increase with development of glaucomatous damage is a common complication of uveitis. The prevalence has a wide range depending on various factors such as the underlying uveitis type and the duration of the disease. Pathogenetically, a distinction must be made between a secondary angle closure component and the more frequently occurring open-angle glaucoma. In diagnostics, in addition to the clinical optic nerve head assessment, perimetry and tonometry, the use of imaging examination equipment, such as OCT and HRT, are recommended. In the context of uveitic glaucoma, it must be considered in the evaluation, because the glaucoma-typical changes are generally less pronounced or can be concealed by retinal swelling in comparison with other forms of glaucoma. Therapeutically, drug therapy in the form of eye drops continues to be a first-line recommendation, with the use of topical carbonic anhydrase inhibitors or beta-blockers primarily preferred, depending on the contraindications. An operative therapy follows after unsuccessful or inadequate conservative therapy: the adequate surgical technique depends on the respective finding and includes actually techniques such as filtering procedures and glaucoma drainage devices.

PMID:
29739027
DOI:
10.1055/a-0573-9598

Conflict of interest statement

CL: Vortrag für: Optovue, Heidelberg Engineering, Alcon. CH: Vortrag für: Allergan, AbbVie, Novartis, MSD; Advisory Board: Santen, AbbVie.

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center